Publication: 2342

Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates
      QxMD      Google Scholar   
Citation:
Ann Surg vol 262 (3) 434-439
Year:
2015
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Received
Note:
Presented as an Oral Presentation at the 135th Annual meeting of the American Surgical Association, April 2015
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
5
Parents:
2296  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA180821, U10CA180882, P30 CA008748, U10 CA180791, U10CA180791, U10CA180867, U10 CA180882, CA180888, U10CA180821, U10 CA180867, U10 CA180888  
Corr. Author:
 
Authors:
                     
Networks:
CA043, LAPS-CT018, LAPS-MA036, LAPS-NC007, LAPS-NY016, RI005   
Study
CALGB-40603
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
breast-conserving therapy, mastectomy, neoadjuvant therapy, surgery, triple negative breast cancer